Randomized comparison of balloon angioplasty versus coronary stent implantation for total occlusion  by Sato, Yasukazu et al.
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Body Composition A.ffe~..s Exercise Oxygen Uptake 
;ndependectly of Boay weight 
Kyle J. Mclnnis, Gary J, BatadY. Bo,,ton University Medical Center, Boston, 
MA 
The purpose of this study was to determine the effect of extreme levels of 
body fat and fat free mass (FFM) on submaxlmal oxygen uptake (V02) dudng 
treadmill walking. We prospectively evaluated 43 subjects who had the same 
body weight (BW) by dividing them into 3 different groups based on ths:r 
gender and body composition: Obese women (n = 15) (99 :l: 10 kg BW; 42 
:t: 8% fat; 5S ± 6 kg FFM); obese men (n = 14) (99 ± 8 kg BW; 24:1: 5% fat; 
75 ± 7 kg FFM}; and lean, highly muscular male body butlders (n : 14) (99 
4-11 kg BW; 8 4- 3% fat; 90 :l: 7 kg FFM). VO2 was measured by respiratory 
gas analysis at rest & at several submaximal warkrates while walking on the 
treadmill without using handrail support. 
~ 1 2 3 * IL~O.OI ANOVA 
, l~ge  mule men > oh. mela : oh. worn 
At rests and at matched submaximal workrates, lean muscular body 
builders had a significantly higher VO than weight-matched obese men and 
women. The di|ferencas increased as the workrate progressed and reached 
280/0 at the highest workrate. These findings suggest that during treadmill 
walking, levels of body fat and FFM at the extreme range appear to influ. 
ence VO2 independently of body weight. This has particular clinical relevance 
when either fitness level or energy expenditure are evaluated using estimates 
of V02 rather than direct measures. 
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~-]  Is ACCIAHA Lesion Classification Predictive of 
Successful Coronary Intervention in the Era of New 
Devices? 
Edward T.A. Fry, James B, Hermilter, Thomas F. Peters, Chades M. On', 
James VanTassal, Duane C. Berkompas, Frank S. Saltiel, Carmen Ernst, 
Brenda Emer, Bruce F, Waller, Cass A. Pinkerton. St. Vincent Hospital, 
Indianapolis, IN 
New devices for coronary intervention have been developed in an effort 
to improve outcomes, reduce complications, and broaden the spectrum of 
lesions amenable to nonsurgical mvascularization. Angiographic dteda es- 
tab,shed by a joint ACCIAHA task force based on expedence with balloon 
angioplasty in the late 1980s have been used by operators, payers, and 
credentialing bodies to estimate procedural success and risk. To test the 
current applloabUlty of these cdteda in the era of lesion-specific use of new 
devices, we analyzed procedural outcomes of 1085 lesions (ACC/AHA class 
A:8%, B1:42%, B2:35%, C:15%) in 784 consecutive patients using balloon 
angiaplasty (84.1%), stents (16.7°/=), directional athereotomy (1.3%), torah- 
later (6.1%), and extraction atherectomy (2.2%). A single device was us~.~l in 
76.4°/0, two In 22.9% and three in 0.7%. Overall procedural success (residual 
stenosis < 50%, no MI, death, or emergency CABG) was 95.9%: A = 10(W°, 
B1 = 97.3%, B2 = 97.1%, C = 87.40/0 (p < 0.05 C vs A and B). For a given 
lesion class, no difference wa~ 3bserved among devices except f~r type C 
lesions: success with rotablator =66.7% vs 10(7'/o with stents (p < 0.05). By 
univariate analysis, predictors of procedural failure included: lesion > 20 mm 
tong, TIMI-1 flow, calcification, angle > 90~, and chronic total occlusion. 
In conclusion, current procedural results for all coronary interventions are 
much better than predicted by current ACCIAHA criteria. However, selected 
angiographic features and class C lesions are still as3ociated with lower 
rates of success. Development of a new classification system may improve 
prediction of outcomes and enhance appropriate device selection. 
10:45 
~ Recanaiizatlon of Chronic Total Coronary 
Occlusions Using e Laser Guide Wire: The Eu and 
US Total Experience 
R W. Sermys, M. Leon, J. N. Hamburger, J. Papma, W. Rutsch, W. O'Neill, 
D. Mathey, S. Oestede, R. Simon, P. Gilmore, E. Fleck, J. Margolis, 
J. Koolen, F. Liivack, A. Buchwald, J. E. Tcheag. Thoraxcenter, University 
Hospital Rotterdam, The N~.theriands; Washington Hospital Center, 
Washington D.C, 
Despite continuous improvement of mechani~l hardware for coronary an- 
gioplasty, total occlusions (TO) remain a true challenge In the field of inter- 
ventional cardiology. To assess efficacy and safety of the Spactranettcs laser 
guide wire (LG), in 20 European and 10 US centers a multicenter Surveillance 
Study was conducted as a preamble to the European-American randomized 
Total Occlusion Trial with _Angloplasty assisted by Laser guide wire (the TO- 
TAL tdal). Methods: Since May 1994, 306 patients with TO (TIMI 0 or TIMI 
1 flow) were included. Angiographfc exclusion critsda were the absence of 
a visible entry point or the inability to visualize the distal true lumen through 
collateral cimuletion. Results are presented as mean + SD, unless otherwise 
indicated. Results: Analysis was completed in 252 patients (age 60 ± 10 
yrs), (TIMI 0 n -- 202, TIMI 1 n = 50), Vessel distribution was RCA n ~= 129, 
LAD n = 83, and LCX n = 40. The median an§iographic age of occlusion, 
was 12 weeks (range 1-1040), when based on clinical data 27 weeks (range 
2-1040). The OCClusion length wac 18 ± 10 mm. By using the LG, the TO was 
successfully crossed in 145 patients (.58%). LG perforation occurred in fifty- 
four cases (21%), in two patients (0.8°/,,) leading to tamponade (non-surgical 
drainage) due to the advancement of an angioplasty device over the LG into 
the free pericardiel space. In six patients (2.4%) in-hospital serious adverse 
events were reported: four non Q wave Mrs, one repeat PTCA for sub acute 
re-occlusion, one renal failure (due to dye overload) and one retreperitoneal 
bleeding requiring blood transfusion. Conclusion: In awaiting the results of 
the TOTAL trial, these results are encouraging and indicate that the LG is a 
powerful additional tool in the !reatment of TO. 
11:00 
F7"4.~-3-1 AP.giographic Outcomes After Arterial 
Recanalization of Refractory Occlusions With the 
PRIMA" Exdmer Laser Wire 
Jeffrey J. Popma, Martin B. Leon, William O'Neill, Stephen Oestede, 
James Margalis, Ronald Masden, Nell Eigler, Paul Gilmore, Abdet Brahimi, 
Ann Greenberg, William Kerker, Theresa Bucher for the USA TOTAL 
Investigators. Washington Hospital Center, Washington, DC 
Failure to pass conventional guidewires into the distal arterial umen is a 
frequent cause of procedural falture in pts with coronary occlusions (CO). To 
~ssess the safety and efficacy of the PRIMA TM excimer laser wire for coro- 
nary recanalization, we reviewed the outcomes of 56 pts undergoing PTCA 
of CO (angiographic occlusion: 66 wks). All CO had unfavorable anatomy 
or were refractory (38%) to conventional guidewire crossing. Angiography: 
Bilateral coronary artefiography, 520/0; oiplane coronary angiography, 63%. 
Location: RCA, 48%,; LAD, 32%, LCx, 20"/0. Ipsilateral (77%) or contralat- 
erel (70%) collaterals were noted in all pts before PRIMA TM use. Occlusions 
were either blunt (57%), central (27%,), or eceentdc (15%) and in 32% in- 
volved major side branches. The average occlusion length was 12.8 ± 8,4 
mm and average stump diameter was 2.49 • 0,63 mm, Average duration 
of the PRIMA TM attempt was 37 minutes (60 mJ 25-40 Hz); the average 
procedure duration was 2.5 hours. Results: Laser wire recanalizatieo was 
achieved in 35 (63%,) lesions, followed by excimer laser in 17 (49%) pts, 
rotational atherectomy in 2 (9%), and stent placement in 15 (32%). There 
was no death, Q-ABSNO>3ave MI, or emergency CABG, Although perfo- 
rations were noted after the laser wire in 15 (27%) of pts, there were no 
important clinical or angiographic sequellae. Overall procedural success was 
obtained in 34 (61%,) pts. We conclude: PRlY' ~K" wire therapy of refractory or 
unfavorable chronic CO results in an encouraging rate of recanalization with 
infrequent complications and represents an important new tool ;or advanced 
coronary intervenlionalists. 
11:15 
Randomized Comparison of Balloon Angioplasty 
Versus Coronary SLnt  Implantation for Total 
Occlusion 
Yasukazu Sate, Hideyuki Nosaka, Takeshi Kimura, Masakiyo Nobuyoshi. 
Kitakyushu, Kokura Memorial Hospital, Japan 
This prospective randomized trial was designed to assess efficacy of stent 
(ST) in the manag¢ment of total occlusion (TO). Follow up angiography was 
to be studied at 24 hours, 3 and 6 months. Quantitative coronary angiography 
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wa~ performed by using CAPS II system. As of August '95,175 lesions (70%) 
out of 250 screened lesions underwent successful dilatation by 1.5 mm 
balloons. Sixty lesions (34%) were randomized (vessel size ~ 2.5 mm and 
lesion length _< 30 mm by visual estimation) (Balloon (BA) group 30, ST group 
30). All procedures in the CS group were successful without any evidence 
of subacute steel thrombosis, Multiple Stans were used in 17 lesions (57%). 
In the BA group, 9 lesions (30%) requimcl bail-out CS due to delayed distal 
flow(2 lesions)and residual stenosis > 50% (7 lesions) (% diameter stenosis 
74 :l: 5.2% (67-81)). In additional 2 lesions (9%), CS was performed due to 
reocclusion at 24 hours study, 
ST (n = 30) BA (n = 30) P value 
Proximal RD (~'m) 3.14 ± 0.35 2.97 ~ 0.36 NS 
MLD (post) 2,29 :t: 0.47 1.87 ± 0.40 <0.001 
MLD (24 hi's) 2.23 ± 0.41 1.63 ± 0.64 <0.001 
MLD (3-6 M) 1.57 ± 0.60 1.60 -*- 0.72 NS 
Binary restenosls (%) 36 (9/25) 33 (8/24) NS 
TLR (%) 3-" (7/25) 29 (7/24) NS 
RD:  Reference diameter (ram), MLD: Minimal umen diameter (ram), TLR: Target lesion 
revascularizatioe. 
Thus, CS was effective in preventing eady reocolusion and associated with 
larger post and 24 hours MLD. This favorable acute luminal outcome over 
BA was not sustained at 3-6  months follow-up. BA supported by bail-out CS 
was equally effective as elective CS in the management of TO. 
11:30 
~ Coronary Staining Following Successful 
Angioplasty for Total Occlusions: Preliminary 
Results of a Randomlead Trial 
Martyn Thomas, Jane Hancock, Steve Holmberg, Ray W~nwright, 
David Jewitt, Oept of CardiG/ogy, King's College Hospital, UK 
The medium term results of balloon angioplasty for total coronary occlusions 
are ,oDor because of high reoccfusion [RO ! and restenosis [RSi rates. The 
angiographic (minimal luminal diameter [MLD], RO, RS and ejection fraction 
[El=l) and clinical (q~t PTCA, CABG and death) benefit of sleet deployment 
at the occlusion site is unknown. We have rendomised 60 patients to "no 
steel" (Gp A) or'sight" (Gp B) following successful PTCA of a total occlusion. 
Time of occlusion was similar in Gp A and Gp B (9 ± 10 v 14 ± 17 weeks 
respectively, NS). Post procedure angiographic results were significantly 
better in Gp B. 
EF Ret MLD % Stenosis 
Gp A (n = 30) 53.1% ~.5 mm 2.8 mm 19.1% 
Gp B (n = 30) 59.6 % 3.3 mm 3.3 mm - t .1% 
p value NS NS p < 0.01 p < 0.001 
There was no clinical in,patient vessel closure. Six month angiographic 
data is currently available in 40 patients. Coronary patency, residual % 
stenosis and EF is significantly belte, in Gp B. MLD is not statistically different 
in Gp A (1.5 ± 1.3 ram) and Gp B (2.0 ± 1.0 ram). 
EF RO RS % stenosis 
Gp A (n = 20) 58.0 % 6/20 6/20 60.0% 
Gp B (n = 20) 70.1% 1/20 4/20 37.8% 
p value p < 0.05 p < 0.05 NS p < 0.05 
Clinical events in the 2 groups is similar (mean follow up 37 weeks), 
Rpt PTGA CABG Death 
GP A (~ = 30) 4/30 2/30 1/30 
Gp B (n = 30) 2/30 1/30 0/30 
Six month results of this randomised study indicate a significant benefit in 
patency, residual % stenosis and left ventricular function if a stent is deployed 
at the site of occlusion following successful PTCA. 
11:45 
~The for Treating Calcilied Lesions Optimal Strategy 
in Large Vessels: Comparison of Intravascular 
Ultrasound Results of Rotational Atherectomy + 
Adjunctive PTCA, DCA, or Stems 
Gaston R. Dussaiiiant, Gary S. Mintz, Augusto D. Pichard, Kenneth 
M. Kent, Lowell F, Sailer, Jeffrey J, Popma, Carol Wa'-h, Paul Mackel, 
Jennifer Griffin, Kathy Morgan, Tammy Weaver, Martir, % Leon. Washi.'Pgton 
Hospital Center, Washington DC 
Treatment results of rotational athemctomy (RA) in calcified lesions in large 
(> 3 ram) vessals are frequently suboptimal. To determine the best adjuno- 
live device after RA, wo compared acute tntravascular ultrasound results 
(measurement of final lumen area and final diameter stenosis) following RA 
and adjunctive PTCA (N = 235), DCA (N = 120), or Palmaz-Schatz stents (N 
= 83) in lesions matched for reference lumen area and total and superficial 
lesion calcium (Ca): 
RA+ RA+ RA+ Anova 
PTCA DCA Stem p 
Reference lumen area (ram 2) 9.1 ~ 2.5 9.5 • 2.9 9.5 ± 3.0 0.3102 
Total arc of Ca (~) 200±113 201±63 212±105 0.6372 
Arc 0f superficial Ca ( a ) 175±119 175+108 159±120 0.6300 
Real lumen area (ram 2 ) 5.0±1.4 6.5 ~: 1.9 7.1 :E 2.0 <0.0001 
Final diarnetar stsnosia (%) 24±13 16±13 12±12 ~0.0001 
Final lumen area was 300 larger with RA + DCA and 42% larger with RA 
+ Stent than with RA + PTCA. Final DS was 33°/,= smaller with RA + DCA 
and 50°/, smaller with RA + Steel than with RA + PTCA. Furthermore, there 
were no procedural complications (including perforation), no subacute stent 
thrombosis, no major in-hospital complications, and only one 30 day clinical 
event (death due to noncardiae multisystam failure) after RA + Stsnt. We 
conclude: In > 3 mm vessels with calcified lesions, RA + Stent achieves the 
largest lumen and smallest DS (vs RA + PTCA or RA + DCA). Late fcllow-up 
will determine if the superior acute lumen dimensions after RA ÷ Stent result 
in fewer subsequent revascutarization events. 
PTCA in Acute Myocardial Infarction and the 
Influence of Gender on Outcome 
Tuesday, March 26, 1996, 10:30 a.m.-Noon 
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[:Z'-43--'~ Determinants of 30 day and I Year Morlaiity in Acute 
Myocardial Infarction: Benefit of Early Angiography 
Conor F. Lundergan, Jonathan S. Reiner, Allan M. Ross. George 
Washington University, Washington, D.C. 
Independent clinical predictom of 30 day and I year mortality in acute my- 
ocardiat infarction (AMI) have been described previously and have shown 
expected (e.g., age) and unexpected (e.g., height} predictors of mortality. The 
GUSTO-1 Angiographic Tnal data base was used to determine the contn'bu- 
tion of clinical and angiographic variables to 30 day and one year mortality 
by logistic regression analysis in 1L:~O0 patients with 90 minute post treatment 
angiogrsphy. Variables considered to be related to mortality (age, gender, 
diabetes, time to treatment, history of hypertension or previous MI, body 
weight, infarct site, Killip class) were entered into the model in a step~se 
fashion and significance determined. Angiographic v,~riables included infarct 
related arlery (IRA) 90 minute TIMI (0.1 vs 2.3) flow grade, # of diseased 
vessels anti one week post AMI ejection fraction (EF). Independent deter- 
minants of 30 day and one year mortality were: (RR = relative risk; CI = 
contidance limit; NS = not signWc, ant) 
30 Day Mo,'laBty One Year Morlality 
RR 95% CI RR 95% Ct 
Age (< 78, _> 75) 3.8 (23, 6.7) 4.0 (2.5, 6.4) 
Female 2.5 (1.5, 4.2) NS 
Diabete,~ NS 1.7 (1.0, 2.9) 
Body Weight NS 0.97 (0.96, 0.98) 
Mul]ivessel CAD 1.9 (1.2,3.2) 2.0 (1_o.3.1) 
TIMI Flow 3.9 (2.4, 6.6) 2.6 (1.7, 4.2) 
EF (<_ 40, > 40) 3.0 (1.7, 5.5) 3.7 (2.2, 6.0) 
Conc/us/ons: 1. Angiographic variables add significant prognostic informa- 
tion to early and late mortality prediction in AMI beyond that provided by 
clinical variables alone. 2. These data suggest treatment strategies for AM1 
should incorporate determination of eady IRA patency to assess treatment 
efficacy and passsibly optimize Outcome. 3. Early IRA patency improves 
e,=ly and late survival independent of El:. 
10:45 
~-~ Primary for Myocardial Infarction Angioplasty 
ImprovPs Long-Term Survival: PAMI-1 Follow-up 
Christopher Nunn, William O'NeilL Donald Rothbaum, James O'Keefe, Jr., 
Paul Ovedie, Bryan Donohue, Denise Mason, Tom Catiin, Cindy Grines. 
William Beaumont Hospital, Royal Oak, MI 
Randomized ldals of PTCA vemus thrombolytic therapy for acute myocardial 
